From Protocol to Practice: EuroIntervention’s Role in ESC Hot Line 7
Davide Capodanno, Professor of Cardiology at University of Catania, Italy has posted on X:
“To all enthusiasts of platelets, hemostasis, and thrombosis: ESC Hot Line Session 7, focused on antiplatelet therapy in ACS/PCI, is notable for the coincidental fact that all featured trials had their protocol designs published in EuroIntervention. This is gratifying, as it reflects both the trust of leading investigators and the effectiveness of our radar at an early stage.
NEO-MINDSET – Early aspirin withdrawal after PCI for ACS: read more here.
TAILORED-CHIP – Personalized antiplatelet therapy in complex high-risk PCI: read more here.
TARGET-FIRST – Early aspirin discontinuation post-PCI in acute MI: read more here.
DAPT-SHOCK-AMI – Cangrelor in cardiogenic shock: read more here.”
Explore more on Hemostasis Today.
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:23Joseph R. Shaw: Thrombin Generation and the Pharmacodynamics of Oral Anticoagulants